Stockscreener 앱 받기
3.22
7.74%
-0.27
시간 외 거래:
3.09
-0.13
-4.04%
전일 마감가:
$3.49
열려 있는:
$3.18
하루 거래량:
4.40M
Relative Volume:
2.13
시가총액:
$552.05M
수익:
$25.55M
순이익/손실:
$-341.97M
주가수익비율:
-1.15
EPS:
-2.8
순현금흐름:
$-304.44M
1주 성능:
-4.17%
1개월 성능:
-10.31%
6개월 성능:
-23.70%
1년 성능:
-52.65%
1일 변동 폭
$3.025
$3.39
1주일 범위
$3.025
$3.74
52주 변동 폭
$1.775
$10.72
릴레이 테라퓨틱스 Stock (RLAY) Company Profile
명칭
Relay Therapeutics Inc
전화
617-370-8837
주소
60 HAMPSHIRE STREET, CAMBRIDGE
RLAY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
3.22 | 605.20M | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
릴레이 테라퓨틱스 Stock (RLAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-17 | 개시 | Wells Fargo | Equal Weight |
| 2024-09-10 | 재개 | Goldman | Buy |
| 2024-09-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-04-20 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-04-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 개시 | Raymond James | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-09-30 | 개시 | Barclays | Equal Weight |
| 2022-09-02 | 개시 | Stifel | Buy |
| 2022-06-06 | 개시 | Jefferies | Underperform |
| 2022-02-01 | 개시 | Berenberg | Buy |
| 2021-07-21 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-08 | 개시 | JMP Securities | Mkt Outperform |
| 2020-11-05 | 개시 | H.C. Wainwright | Buy |
| 2020-08-10 | 개시 | Cowen | Outperform |
| 2020-08-10 | 개시 | Goldman | Buy |
| 2020-08-10 | 개시 | Guggenheim | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
모두보기
릴레이 테라퓨틱스 주식(RLAY)의 최신 뉴스
Will Relay Therapeutics Inc. continue its uptrendReal Time Growth Signal with Smart Setup - Newser
Why Relay Therapeutics Inc. stock attracts strong analyst attentionGrowth Watchlist for Long Term Positioning - Newser
Relay Therapeutics (NASDAQ:RLAY) Shares Gap Down After Analyst Downgrade - Defense World
RLAY.O Drops 11.7%: Uncovering the Forces Behind the Sudden Move - AInvest
A Quick Look at Today's Ratings for Relay Therapeutics(RLAY.US), With a Forecast Between $4 to $17 - 富途牛牛
Wells Fargo reiterates Equal Weight rating on Relay Therapeutics stock By Investing.com - Investing.com Canada
Relay Therapeutics Reports Q2 2025 Financial Results and Progress - TipRanks
Relay Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Relay Therapeutics reports Q2 EPS (41c), consensus (47c) - TipRanks
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates | RLAY Stock News - GuruFocus
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates - Stock Titan
Barclays Reiterates a Buy Rating on Relay Therapeutics (RLAY) - MSN
Relay Therapeutics Q2 2025 Financial Results and Corporate Highlights Announced for August 7, 2025 - AInvest
What’s the recovery path for long term holders of Relay Therapeutics Inc.Free Capital Preserving Trade Plan Templates - Newser
Relay Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowMomentum Screener with Buy and Sell Areas - Newser
Relay Therapeutics Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
Barclays Maintains a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT - MSN
Relay Therapeutics (RLAY) Expected to Announce Earnings on Thursday - Defense World
What makes Relay Therapeutics Inc. stock price move sharplyUnprecedented profits - Jammu Links News
10 Best Strong Buy Penny Stocks to Buy Now - Insider Monkey
How does Relay Therapeutics Inc. generate profit in a changing economyOutstanding stock performance - Jammu Links News
Should I hold or sell Relay Therapeutics Inc. stock in 2025Build a winning investment strategy today - Jammu Links News
Is Relay Therapeutics Inc. a good long term investmentDynamic profit opportunities - jammulinksnews.com
What are the latest earnings results for Relay Therapeutics Inc.Unlock exclusive stock market insights - Jammu Links News
Why is Relay Therapeutics Inc. stock attracting strong analyst attentionStay ahead with daily expert stock picks - Jammu Links News
Critical Survey: SHINECO (NASDAQ:SISI) vs. Relay Therapeutics (NASDAQ:RLAY) - Defense World
What catalysts could drive Relay Therapeutics Inc. stock higher in 2025Discover stocks with superior performance - Jammu Links News
What drives Relay Therapeutics Inc. stock priceMaximize portfolio growth with professional advice - Jammu Links News
How does Relay Therapeutics Inc. compare to its industry peersGet alerts on high-potential market moves - Jammu Links News
Relay Therapeutics (RLAY): Is H2 2025 the Inflection Point for AI-Driven Drug Discovery? - AInvest
Relay Therapeutics: What's Next For H2 2025? - Seeking Alpha
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025 - 富途牛牛
Relay Therapeutics’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment - TipRanks
Precision Medicine Pioneer Relay Therapeutics Sets Q2 Earnings Date: AI-Driven Drug Discovery Results Coming - Stock Titan
Relay Therapeutics Inc. stock outlook for YEARLow-Risk Reversal Pattern Analysis Tracker - Newser
Relay Therapeutics president sells $113k in stock By Investing.com - Investing.com Nigeria
Rahmer Peter sells Relay Therapeutics (RLAY) stock worth $62,946 By Investing.com - Investing.com Canada
Relay Therapeutics CFO Catinazzo sells $74,000 in stock By Investing.com - Investing.com South Africa
Relay Therapeutics CFO Catinazzo sells $74,000 in stock - Investing.com
Relay Therapeutics president sells $113k in stock - Investing.com
Relay Therapeutics Executives Sell Shares - TradingView
Published on: 2025-07-29 23:02:46 - metal.it
Relay Therapeutics has positive read from Celcuity data, says Barclays - The Globe and Mail
Published on: 2025-07-29 04:36:35 - beatles.ru
What is the risk reward ratio of investing in Relay Therapeutics Inc. stockMarket Forecast Opportunities Backed By Experts - Jammu Links News
When is Relay Therapeutics Inc. stock expected to show significant growthStock Strategy Tracker With High Returns - Jammu Links News
Price Floor Holding on Relay Therapeutics Inc. — Rebound PossibleProfit Focused Stock Screener Results Released - metal.it
What are the technical indicators suggesting about Relay Therapeutics Inc.Achieve breakthrough performance in the market - jammulinksnews.com
릴레이 테라퓨틱스 (RLAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):